002864.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:04):

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells drugs and GAP cultivation of medicinal materials in China...

Stats
Dzisiejszy wolumen	3.78M
Średni wolumen	3.96M
Kapitalizacja rynkowa	3.07B
EPS	CNY0.331 ( 2023-09-30 )
Następna data zysków	( CNY0 ) 2024-05-21
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	24.30
ATR14	CNY0.0180 (0.06%)

Wolumen Korelacja

Długi: 0.01 (neutral)

Krótki: 0.00 (neutral)

Signal:(47.8) Neutral

Shaanxi Panlong Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Shaanxi Panlong Korelacja - Waluta/Towar

0.65
( moderate )

0.32
( neutral )

0.00
( neutral )

0.60
( weak )

-0.10
( neutral )

0.24
( neutral )

Shaanxi Panlong Finanse

Annual	2023
Przychody:	CNY980.83M
Zysk brutto:	CNY568.08M (57.92 %)
EPS:	CNY1.150

FY	2023
Przychody:	CNY980.83M
Zysk brutto:	CNY568.08M (57.92 %)
EPS:	CNY1.150

FY	2022
Przychody:	CNY974.29M
Zysk brutto:	CNY566.28M (58.12 %)
EPS:	CNY1.180

FY	2021
Przychody:	CNY887.48M
Zysk brutto:	CNY517.21M (58.28 %)
EPS:	CNY1.090

Financial Reports:

No articles found.

Shaanxi Panlong

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells drugs and GAP cultivation of medicinal materials in China. It offers orthopedic, cardio-cerebrovascular, digestive, supplement category, respiratory, Chinese anti-inflammatory, pediatric, gynecology, hepatobiliary, and specialty drugs. The company was founded in 1997 and is headquartered in Xi'an, China.